ANTI-ICAM-1 ANTIBODIES AND METHODS OF USE
Provided are anti-ICAM-1 antibodies or antibody fragments and methods of using them. In certain embodiments, anti-ICAM-1 antibodies or antibody fragments of the invention inhibit binding of human ICAM-1 to human rhinovirus, and do not substantially inhibit binding of human ICAM-1 to LFA1. L'inv...
Gespeichert in:
| Hauptverfasser: | , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | WELLS, EDWARD STRAIN, MARTIN DOUGLAS DODD, SARA NEWTON, PHILIP ARTHUR LOWE, DAVID CHRISTOPHER VOUSDEN, KATHERINE ANN |
| description | Provided are anti-ICAM-1 antibodies or antibody fragments and methods of using them. In certain embodiments, anti-ICAM-1 antibodies or antibody fragments of the invention inhibit binding of human ICAM-1 to human rhinovirus, and do not substantially inhibit binding of human ICAM-1 to LFA1.
L'invention concerne des anticorps ou des fragments d'anticorps anti-ICAM-1 et leurs procédés d'utilisation. Dans certaines formes de réalisation, les anticorps ou les fragments d'anticorps anti-ICAM-1 de l'invention inhibent la liaison de l'ICAM-1 humain au rhinovirus humain, et n'inhibent pratiquement pas la liaison de l'ICAM-1 humain à LFA1. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO2012022734A3</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO2012022734A3</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO2012022734A33</originalsourceid><addsrcrecordid>eNrjZNB09Avx1PV0dvTVNVQAsZ38XTxdg4FMFwVf1xAPf5dgBX83hdBgVx4G1rTEnOJUXijNzaDs5hri7KGbWpAfn1pckJicmpdaEh_ub2RgaGRgZGRubOJobEycKgB8kSSu</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>ANTI-ICAM-1 ANTIBODIES AND METHODS OF USE</title><source>esp@cenet</source><creator>WELLS, EDWARD ; STRAIN, MARTIN DOUGLAS ; DODD, SARA ; NEWTON, PHILIP ARTHUR ; LOWE, DAVID CHRISTOPHER ; VOUSDEN, KATHERINE ANN</creator><creatorcontrib>WELLS, EDWARD ; STRAIN, MARTIN DOUGLAS ; DODD, SARA ; NEWTON, PHILIP ARTHUR ; LOWE, DAVID CHRISTOPHER ; VOUSDEN, KATHERINE ANN</creatorcontrib><description>Provided are anti-ICAM-1 antibodies or antibody fragments and methods of using them. In certain embodiments, anti-ICAM-1 antibodies or antibody fragments of the invention inhibit binding of human ICAM-1 to human rhinovirus, and do not substantially inhibit binding of human ICAM-1 to LFA1.
L'invention concerne des anticorps ou des fragments d'anticorps anti-ICAM-1 et leurs procédés d'utilisation. Dans certaines formes de réalisation, les anticorps ou les fragments d'anticorps anti-ICAM-1 de l'invention inhibent la liaison de l'ICAM-1 humain au rhinovirus humain, et n'inhibent pratiquement pas la liaison de l'ICAM-1 humain à LFA1.</description><language>eng ; fre</language><subject>CHEMISTRY ; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC ; GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS ; HUMAN NECESSITIES ; HYGIENE ; INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES ; MEASURING ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES ; PHYSICS ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS ; TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE ; TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINSTCLIMATE CHANGE ; TESTING</subject><creationdate>2012</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20120503&DB=EPODOC&CC=WO&NR=2012022734A3$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20120503&DB=EPODOC&CC=WO&NR=2012022734A3$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>WELLS, EDWARD</creatorcontrib><creatorcontrib>STRAIN, MARTIN DOUGLAS</creatorcontrib><creatorcontrib>DODD, SARA</creatorcontrib><creatorcontrib>NEWTON, PHILIP ARTHUR</creatorcontrib><creatorcontrib>LOWE, DAVID CHRISTOPHER</creatorcontrib><creatorcontrib>VOUSDEN, KATHERINE ANN</creatorcontrib><title>ANTI-ICAM-1 ANTIBODIES AND METHODS OF USE</title><description>Provided are anti-ICAM-1 antibodies or antibody fragments and methods of using them. In certain embodiments, anti-ICAM-1 antibodies or antibody fragments of the invention inhibit binding of human ICAM-1 to human rhinovirus, and do not substantially inhibit binding of human ICAM-1 to LFA1.
L'invention concerne des anticorps ou des fragments d'anticorps anti-ICAM-1 et leurs procédés d'utilisation. Dans certaines formes de réalisation, les anticorps ou les fragments d'anticorps anti-ICAM-1 de l'invention inhibent la liaison de l'ICAM-1 humain au rhinovirus humain, et n'inhibent pratiquement pas la liaison de l'ICAM-1 humain à LFA1.</description><subject>CHEMISTRY</subject><subject>GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC</subject><subject>GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES</subject><subject>MEASURING</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PHYSICS</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS</subject><subject>TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE</subject><subject>TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINSTCLIMATE CHANGE</subject><subject>TESTING</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2012</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZNB09Avx1PV0dvTVNVQAsZ38XTxdg4FMFwVf1xAPf5dgBX83hdBgVx4G1rTEnOJUXijNzaDs5hri7KGbWpAfn1pckJicmpdaEh_ub2RgaGRgZGRubOJobEycKgB8kSSu</recordid><startdate>20120503</startdate><enddate>20120503</enddate><creator>WELLS, EDWARD</creator><creator>STRAIN, MARTIN DOUGLAS</creator><creator>DODD, SARA</creator><creator>NEWTON, PHILIP ARTHUR</creator><creator>LOWE, DAVID CHRISTOPHER</creator><creator>VOUSDEN, KATHERINE ANN</creator><scope>EVB</scope></search><sort><creationdate>20120503</creationdate><title>ANTI-ICAM-1 ANTIBODIES AND METHODS OF USE</title><author>WELLS, EDWARD ; STRAIN, MARTIN DOUGLAS ; DODD, SARA ; NEWTON, PHILIP ARTHUR ; LOWE, DAVID CHRISTOPHER ; VOUSDEN, KATHERINE ANN</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO2012022734A33</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2012</creationdate><topic>CHEMISTRY</topic><topic>GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC</topic><topic>GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES</topic><topic>MEASURING</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PHYSICS</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS</topic><topic>TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE</topic><topic>TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINSTCLIMATE CHANGE</topic><topic>TESTING</topic><toplevel>online_resources</toplevel><creatorcontrib>WELLS, EDWARD</creatorcontrib><creatorcontrib>STRAIN, MARTIN DOUGLAS</creatorcontrib><creatorcontrib>DODD, SARA</creatorcontrib><creatorcontrib>NEWTON, PHILIP ARTHUR</creatorcontrib><creatorcontrib>LOWE, DAVID CHRISTOPHER</creatorcontrib><creatorcontrib>VOUSDEN, KATHERINE ANN</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>WELLS, EDWARD</au><au>STRAIN, MARTIN DOUGLAS</au><au>DODD, SARA</au><au>NEWTON, PHILIP ARTHUR</au><au>LOWE, DAVID CHRISTOPHER</au><au>VOUSDEN, KATHERINE ANN</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>ANTI-ICAM-1 ANTIBODIES AND METHODS OF USE</title><date>2012-05-03</date><risdate>2012</risdate><abstract>Provided are anti-ICAM-1 antibodies or antibody fragments and methods of using them. In certain embodiments, anti-ICAM-1 antibodies or antibody fragments of the invention inhibit binding of human ICAM-1 to human rhinovirus, and do not substantially inhibit binding of human ICAM-1 to LFA1.
L'invention concerne des anticorps ou des fragments d'anticorps anti-ICAM-1 et leurs procédés d'utilisation. Dans certaines formes de réalisation, les anticorps ou les fragments d'anticorps anti-ICAM-1 de l'invention inhibent la liaison de l'ICAM-1 humain au rhinovirus humain, et n'inhibent pratiquement pas la liaison de l'ICAM-1 humain à LFA1.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; fre |
| recordid | cdi_epo_espacenet_WO2012022734A3 |
| source | esp@cenet |
| subjects | CHEMISTRY GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS HUMAN NECESSITIES HYGIENE INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES MEASURING MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PHYSICS PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINSTCLIMATE CHANGE TESTING |
| title | ANTI-ICAM-1 ANTIBODIES AND METHODS OF USE |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T06%3A37%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=WELLS,%20EDWARD&rft.date=2012-05-03&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO2012022734A3%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |